Information Provided By:
Fly News Breaks for December 5, 2017
NEOG
Dec 5, 2017 | 07:15 EDT
Roth Capital re-established coverage of Neogen with a Neutral rating and an $82 price target, with analyst Gerry Sweeney seeing "brisk tailwinds" in its end markets but recommending waiting for a pullback citing its valuation near historic highs.